Dynavax Technologies logo

Dynavax Technologies

BrandEmeryville, CaliforniaWebsite

Company Overview

Dynavax is a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines to help protect the world against infectious diseases. The Company has two commercial products, HEPLISAV-B® vaccine [Hepatitis B Vaccine (Recombinant), Adjuvanted], which is approved in the U.S., the European Union and the United Kingdom for the prevention of infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older, and CpG 1018® adjuvant, currently used in HEPLISAV-B and multiple adjuvanted COVID-19 vaccines. For more information about our marketed products and development pipeline, visit www.dynavax.com and follow Dynavax on LinkedIn.Dynavax is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital and veteran status.
Founded
1996
Headquarters
Emeryville, California
Employees
201-500
3.3% last 12mo
Marketing Team
9
3% of company

Overall Headcount Trend

Overall Headcount Trend

Company growth over the last 12 months

Salaries

Job Posting Salary Data

From 1 marketing roles posted in the last 12 months

Typical Salary Range
$275,000$301,000
YEAR
100%
share salary

Community Salary Data

Help build salary transparency at Dynavax Technologies. Share your compensation anonymously.

Contribute

Reviews

Jobs